Legal Representation
Attorney
Charles T. J. Weigell
USPTO Deadlines
Next Deadline
624 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-04-13)
Due Date
April 13, 2027
Grace Period Ends
October 13, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
39 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 14, 2021 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Jul 26, 2021 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Jul 26, 2021 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Jul 13, 2021 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Jun 4, 2021 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Apr 13, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jan 26, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 26, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 24, 2021 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Jan 6, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 6, 2021 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Jan 6, 2021 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Dec 21, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Dec 21, 2020 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 21, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 21, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Dec 21, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 14, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 14, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 11, 2020 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 18, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 5, 2020 | LIME | X | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | Loading... |
| Aug 5, 2020 | ATRV | O | ATTORNEY REVIEW COMPLETED | Loading... |
| Jul 27, 2020 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jul 27, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jul 27, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jul 27, 2020 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | Loading... |
| Jul 27, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jul 27, 2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| May 22, 2020 | LIMG | M | LIMITATION OF GOODS RECEIVED FROM IB | Loading... |
| Apr 10, 2020 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Mar 20, 2020 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Mar 20, 2020 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Mar 4, 2020 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Mar 3, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 2, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 18, 2020 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Feb 14, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 13, 2020 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations and biologic medicines used in the treatment of angiogenesis and ocular diseases and disorders as well as angiogenesis and ocular conditions related to diabetic, oncological, macular and vascular diseases and disorders; dietetic food adapted for medical use; dietary supplements for humans
First Use Anywhere:
0
First Use in Commerce:
0
Class 010
Applicators in the nature of droppers and syringes for administering medications into the human eye, sold empty; medical apparatus for introducing pharmaceutical preparations into the human body; diagnostic apparatus for detecting angiogenesis and ocular diseases and disorders for medical purposes
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Translation
The wording "MACLIRYS" has no meaning in a foreign language.
Classification
International Classes
005
010